Culprit site maxTBR | ||||||||||||
Patient no. | Sex | Age (y) | Body mass index (kg/m2) | Presentation | Culprit site location | Peak troponin I (ng/mL) | Type of stent | Myocardial uptake score* | Reader 1 | Reader 2 | Consensus | Aortic maxTBR, consensus |
Acute myocardial infarction | ||||||||||||
1 | Female | 56 | 30.6 | STEMI | Proximal LAD | >250 | BMS | 1 | 1.3 | 1.5 | 1.4 | 2.0 |
2 | Male | 54 | 25.2 | STEMI | Proximal LAD | 145 | DES | 2 | 2.1 | 2.9 | 2.1 | 1.4 |
3 | Male | 55 | 24.5 | STEMI | Proximal LAD | >250 | BMS | 3 | 3.1 | 2.5 | 3.1 | 1.5 |
4 | Male | 62 | 20.0 | STEMI | Proximal LAD | 19 | DES | 3 | 2.3 | 2.3 | 2.3 | 2.0 |
5 | Male | 65 | 27.2 | STEMI | Proximal LAD | 20 | DES | 2 | 2.1 | 2.1 | 2.1 | 1.9 |
6 | Male | 52 | 25.1 | NSTEMI | Mid LCX | 49 | DES | 2 | 3.2 | 4.6 | 3.5 | 1.4 |
7 | Male | 62 | 25.8 | STEMI | Mid LCX | 20 | BMS | 3 | 2.3 | 1.8 | 2.5 | 2.3 |
8 | Male | 71 | 25.9 | STEMI | Mid LCX | >250 | BMS | 3 | 3.8 | 2.7 | 4.0 | 1.8 |
9 | Female | 69 | 27.7 | STEMI | Proximal RCA | 15 | BMS | 0 | 1.8 | 1.9 | 1.9 | 1.3 |
10 | Male | 49 | 24.5 | STEMI | Proximal RCA | 144 | BMS | 0 | 2.1 | 2.1 | 2.1 | 1.9 |
11 | Male | 53 | 19.7 | STEMI | Proximal RCA | 125 | BMS | 1 | 1.8 | 1.7 | 1.8 | 2.3 |
12 | Male | 61 | 22.9 | STEMI | Proximal RCA | 90 | DES | 2 | 2.3 | 1.7 | 2.6 | 2.3 |
13 | Male | 66 | 25.9 | STEMI | Proximal RCA | 17 | DES | 1 | 1.2 | 1.2 | 1.2 | 1.8 |
14 | Male | 82 | 23.3 | STEMI | Proximal RCA | 42 | DES | 1 | 1.7 | 1.7 | 1.7 | 1.3 |
15 | Female | 56 | 29.5 | STEMI | Mid RCA | 77 | DES | 1 | 1.2 | 0.9 | 1.2 | 2.0 |
16 | Male | 77 | 29.3 | NSTEMI | Mid RCA | 57 | DES | 1 | 0.8 | 0.8 | 0.8 | 1.7 |
17 | Male | 55 | 28.2 | STEMI | Distal RCA | 110 | BMS | 0 | 2.4 | 2.5 | 2.4 | 1.9 |
18 | Male | 63 | 26.8 | NSTEMI | Distal RCA | 1 | BMS | 1 | 1.3 | 1.2 | 1.3 | 1.3 |
19 | Male | 68 | 30.5 | NSTEMI | Distal RCA | 1 | DES | 1 | 2.1 | 2.1 | 2.1 | 1.2 |
20 | Female | 67 | 28.0 | STEMI | Distal RCA | 34 | DES | 1 | 2.2 | 2.5 | 2.5 | 1.3 |
Stable CAD | ||||||||||||
21 | Male | 54 | 26.5 | Angina, abnormal MPI | Proximal LAD | — | DES | 1 | 1.2 | 1.3 | 1.3 | 1.5 |
22 | Male | 67 | 32.4 | Abnormal MPI | Proximal LAD | — | BMS | 3 | 1.6 | 1.7 | 1.7 | 1.6 |
23 | Female | 54 | 22.9 | Angina, abnormal ETT | Mid LAD | — | DES | 0 | 1.6 | 1.7 | 1.7 | 1.5 |
24 | Female | 52 | 28.5 | Angina, abnormal EEC | Mid LAD | — | DES | 3 | 1.5 | 1.5 | 1.5 | 1.6 |
25 | Female | 68 | 28.1 | Angina, abnormal MPI | Mid LCX | — | DES | 3 | 2.4 | 2.4 | 2.4 | 1.0 |
26 | Male | 80 | 26.4 | Abnormal MPI | Proximal RCA | — | BMS | 0 | 1.3 | 1.5 | 1.4 | 1.8 |
27 | Male | 71 | 26.0 | Angina, abnormal ETT | Mid RCA | — | DES | 1 | 1.5 | 1.9 | 1.5 | 2.2 |
↵* Achievement of desired myocardial uptake suppression was defined as a score of less than 2.
STEMI = ST segment elevation myocardial infarction; LAD = left anterior descending; BMS = bare-metal stent; DES = drug-eluting stent; NSTEMI = non–ST segment elevation myocardial infarction; LCX = left circumflex; MPI = myocardial perfusion imaging; ETT = exercise treadmill test; EEC = exercise echo.